December 26, 2025

RxSight, Inc. (RXST)

⚠️ No article content returned.

..

Xeris Biopharma Holdings, Inc. (XERS): Investor Outlook with a 54.55% Potential Upside

Xeris Biopharma Holdings, Inc. (XERS) is making significant strides in the biotechnology sector, specializing in the development and commercialization of therapies for chronic endocrine and neurological..

Weave Communications (WEAV) Stock Analysis: Exploring a 48.39% Potential Upside

Weave Communications, Inc. (NYSE: WEAV), a key player in the healthcare sector, is making waves with its innovative customer experience and payments software platform tailored for..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Exploring Key Metrics and 31.40% Revenue Growth

For investors focused on the healthcare sector, particularly in the specialty and generic drug manufacturing industry, Collegium Pharmaceutical, Inc. (NASDAQ: COLL) presents a compelling case. Situated..

Nutex Health Inc. (NUTX) Stock Analysis: Exploring a 48.72% Potential Upside with Robust Revenue Growth

For investors seeking opportunities in the healthcare sector, Nutex Health Inc. (NUTX) presents a compelling case with its significant growth potential. Currently priced at $168.1, Nutex..

Syndax Pharmaceuticals (SNDX) Stock Analysis: A Biotech Gem with 82% Potential Upside

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is capturing investor attention with its promising pipeline in the biotechnology sector, particularly with a potential upside of nearly 82%. As..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Exploring a 46.75% Potential Upside in the Biotech Sector

Nurix Therapeutics, Inc. (NRIX), a San Francisco-based clinical-stage biopharmaceutical company, is capturing investor attention with its robust pipeline and strategic partnerships in the biotechnology sector. With..

Beta Bionics, Inc. (BBNX) Stock Analysis: A Promising Growth Story with 63.10% Revenue Surge

Beta Bionics, Inc. (NASDAQ: BBNX) stands at the forefront of innovation in the healthcare sector, specifically within the medical devices industry. With a market capitalization of..

Oculis Holding AG (OCS) Stock Analysis: Eyeing a 117% Upside in Healthcare Innovation

Oculis Holding AG (NASDAQ: OCS), a burgeoning name in the biotechnology sector, is capturing investor attention with its promising pipeline of ophthalmic treatments and a compelling..

Enliven Therapeutics, Inc. (ELVN) Stock Analysis: A Biotech Powerhouse with 147% Potential Upside

Enliven Therapeutics, Inc. (NASDAQ: ELVN), a burgeoning player in the biotechnology sector, is capturing attention with its promising pipeline and significant growth potential. Based in Boulder,..

STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth in the Medical Instruments Space

STAAR Surgical Company (NASDAQ: STAA) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Lake Forest, California,..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a Challenging Market with a 6.1% Revenue Growth

Cronos Group Inc. (NASDAQ: CRON), a prominent player in the healthcare sector specializing in cannabinoid products, finds itself at a pivotal moment. With a current market..

Zymeworks Inc. (ZYME) Stock Analysis: Unveiling a 32% Upside Potential Amidst Robust Revenue Growth

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology firm, is making waves in the healthcare sector with its focus on developing innovative biotherapeutics for cancer and autoimmune..

Phibro Animal Health Corporation (PAHC) Stock Analysis: Navigating a 13.94% Upside in the Healthcare Sector

Phibro Animal Health Corporation (NASDAQ: PAHC), a stalwart in the healthcare sector, stands out with its diverse portfolio in animal health and mineral nutrition. With a..

Nuvation Bio Inc. (NUVB) Investor Outlook: A 1,704% Revenue Growth Story with an 18% Upside Potential

Nuvation Bio Inc. (NASDAQ: NUVB), a promising name in the biotechnology sector, has been capturing investor interest with its remarkable financial metrics and ambitious oncology-focused pipeline...

Avadel Pharmaceuticals plc (AVDL): Navigating a Tightrope with a 54.9% Revenue Growth and Investor Caution

Avadel Pharmaceuticals plc (AVDL) is capturing the attention of investors with its impressive 54.9% revenue growth. Operating from Dublin, Ireland, this biopharmaceutical company is making waves..

Pharvaris N.V. (PHVS): An Investor Outlook with a Promising 79% Upside

Pharvaris N.V. (PHVS), a Swiss biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to treating rare diseases. With a focus on..

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 42.68% Potential Upside Amid Healthcare SaaS Growth

HealthStream, Inc. (NASDAQ: HSTM), a key player in the health information services industry, presents an intriguing opportunity for investors amid a robust healthcare sector. Headquartered in..

AMN Healthcare Services Inc (AMN): Investor Outlook with 27.6% Potential Upside

For investors eyeing opportunities within the healthcare sector, AMN Healthcare Services Inc (NYSE: AMN) presents a compelling case. As a leading provider of technology-enabled healthcare workforce..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Navigating the 38.84% Upside Potential in the Biotech Arena

Arcus Biosciences, Inc. (NASDAQ: RCUS), a trailblazer in the biotech sector, is captivating investor interest with its promising pipeline of cancer therapies and a notable potential..

Search

Funds

December 26, 2025

Search

Funds

December 26, 2025

FTSE 100

Funds